- What the DACVCP Credential Actually Is
- The Two-Phase Pathway
- Phase I: Foundations and Organ-System Pharmacology
- Phase II: Applied Categories and Written Responses
- Eligibility and the Publication Requirement
- Fees, Deadlines and the Five-Year Window
- Remote Delivery and Exam-Day Logistics
- What Is Not Published About Scoring
- Careers and Maintenance After Certification
- Sequencing Your Preparation by Domain
- Frequently Asked Questions
- DACVCP means Diplomate, American College of Veterinary Clinical Pharmacology; the credential requires passing both Phase I and Phase II.
- Phase I is 200 multiple-choice questions in two 100-question sessions; Phase II is ten question groups worth 200 points.
- Phase II eligibility requires two peer-reviewed papers accepted or published by February 1 of the examination year.
- Both phases must be passed within a five-year eligibility window that starts after Phase I approval.
What the DACVCP Credential Actually Is
The DACVCP designates a Diplomate of the American College of Veterinary Clinical Pharmacology (ACVCP), the specialty organization that governs and administers the credential. It signals advanced, board-recognized expertise in how drugs behave in animals: how they move through the body, how they act, why they sometimes fail, and how they should be dosed, monitored and regulated. If you are new to the terminology, the explainers on what DACVCP is and what DACVCP stands for cover the basics before you get into exam logistics.
This is a specialty credential built around residency training, not a standalone test you register for after a study sprint. Candidates must be legally qualified to practice veterinary medicine and enrolled in, or have completed, approved ACVCP residency training. Approved institutional and alternate training routes are described by the college in its resident-pathway pages, and the broader context is covered in our overview of DACVCP training.
The Two-Phase Pathway
The complete credential requires both Phase I and Phase II. They test different things and carry different prerequisites, so it helps to see them side by side.
| Feature | Phase I | Phase II |
|---|---|---|
| Format | 200 multiple-choice questions in two 100-question sessions | Ten question groups using written responses, multiple choice, fill-in-the-blank and extended matching |
| Size measure | 200 questions | 200 points across two 100-point sessions (a point total, not a question count) |
| Ordinary schedule | 08:00-12:00 and 14:00-18:00 local time | Ordinarily eight active hours as well |
| Prerequisite | Legal qualification to practice; approved residency enrollment or completion; two references | Completed training, Phase I pass, approved credentials, documentation, two qualifying papers |
| 2026 date (published) | May 19 | June 30 |
Both administrations in the published 2026 cycle were delivered remotely using ExamSoft. Those dates have passed, and a 2027 schedule had not been verified at the time of writing, so check the college's candidate information page before planning. Our guide to DACVCP exam dates and deadlines tracks the scheduling details.
Phase I: Foundations and Organ-System Pharmacology
The college has published a suggested Phase I blueprint, last revised December 2021, which lists 22 preparation headings. Treat these as a dated preparation curriculum rather than a verified current or exhaustive exam outline. The current Phase I blueprint document could not be retrieved during verification, so the headings below are the best publicly indexed guide to what Phase I preparation should cover. The headings fall into two natural clusters. For the full breakdown, see our complete guide to all 26 content areas.
Cluster 1: Core principles (Domains 1-9)
Domain 1: Physiochemical characteristics of active pharmaceutical ingredients
The blueprint spells this heading "Physiochemical," and that spelling is retained here. Expect to reason from molecular properties to behavior in the body.
- Ionization, pKa and the effect of pH on absorption and distribution
- Lipophilicity, solubility and stability as determinants of formulation and movement
Domains 2-4: Pharmacodynamics, Drug movement, Pharmacokinetics
These three headings form the quantitative backbone of the discipline. Pharmacodynamics covers how drugs produce effects; drug movement covers how molecules cross membranes and distribute; pharmacokinetics covers the mathematics of absorption, distribution, metabolism and elimination.
- Be comfortable interpreting concentration-time data and the parameters derived from it
- Connect receptor-level concepts to dose-response behavior
Domains 5-9: Variability, routes, dosing forms, adverse events, therapeutic failure
This group asks why the same drug behaves differently across animals and circumstances.
- Factors impacting drug movement and/or drug response, including species and individual variation
- Routes of administration and dosing forms (and relevant drug delivery devices)
- Adverse events and the causes for therapeutic failure
Cluster 2: Organ systems and drug classes (Domains 10-22)
The remaining Phase I headings walk through body systems and therapeutic categories: Nervous System, Renal, Cardiovascular, Gastrointestinal, Reproduction, Endocrine, General and special senses, Control of inflammation/immunomodulation, Anticancer drugs, Fluid therapy, Anti-infectives, Botanical/Herbals, and Disinfectants/antiseptics. Notice the breadth: this list spans classic systemic pharmacology and several niches, such as botanicals and antiseptics, that candidates sometimes under-prepare because they sit outside daily clinical practice.
Phase II: Applied Categories and Written Responses
The current Phase II examination page lists four subject categories, and these correspond to Domains 23-26 in our domain list: Therapeutics; Pharmacokinetics and Therapeutic Drug Monitoring; Experimental Design, Statistics and Analytical Methods; and Regulatory Pharmacology. The current category percentages are not published on that page, and the separately indexed Phase II suggested blueprint (last revised December 2021) contains only historical question allocations. Those historical figures should not be treated as current weights.
Domain 23: Therapeutics
Applying pharmacology to patient-level decisions, where written responses reward structured reasoning rather than recall.
- Selecting, justifying and adjusting regimens for realistic clinical scenarios
- Explaining the pharmacologic rationale, not just naming the drug
Domain 24: Pharmacokinetics and Therapeutic Drug Monitoring
This is the applied counterpart of Phase I pharmacokinetics. Expect to work with data and defend interpretations.
- Using measured concentrations to guide dosing decisions
- Recognizing the limits and assumptions of monitoring strategies
Domain 25: Experimental Design, Statistics and Analytical Methods
A distinguishing feature of this specialty. Candidates are expected to evaluate and design studies, not merely consume results.
- Study design choices and their consequences for inference
- Statistical reasoning and the analytical methods used to quantify drugs
Domain 26: Regulatory Pharmacology
How drugs are evaluated, approved, labeled and overseen. Prepare to reason about regulatory frameworks rather than memorize isolated rules.
Because Phase II mixes written responses, multiple choice, fill-in-the-blank and extended matching across ten question groups, the format rewards candidates who can move between recall, calculation and prose. Practice writing complete answers under time pressure, not only recognizing correct options.
Eligibility and the Publication Requirement
For Phase I, the application requires two references and proof that you are legally qualified to practice veterinary medicine and enrolled in or have completed approved residency training. Phase II is considerably more demanding on paperwork. The credentials review requires:
- Completed approved training
- A Phase I pass
- Approved credentials, course documentation and transcripts
- Two peer-reviewed papers accepted or published by February 1 of the examination year
The paper rules are specific. At least one paper must be original veterinary clinical pharmacology research; the other may be original research or an eligible evidence-based systematic review/meta-analysis. First authorship is required on at least one. Neither paper may have been used for another specialty board, and publication must not predate the beginning of training by more than two years.
Key Takeaway
Start the publication pipeline early in residency. A paper that is not accepted or published by February 1 of the examination year can delay your Phase II sitting regardless of how well you perform on Phase I. For the full checklist, see our guide to DACVCP requirements.
Fees, Deadlines and the Five-Year Window
The college's published fee schedule for the 2026 cycle lists the following amounts. For a fuller breakdown, see our DACVCP certification cost guide.
| Item | 2026 published fee |
|---|---|
| Phase I application | USD 75 |
| Phase I examination | USD 200 |
| Phase II credentials review | USD 250 |
| Phase II examination | USD 300 |
Two cautions apply. First, the resident-pathway page separately describes USD 75 as a first-year candidate registration fee, and the public pages do not establish whether this is the same charge as the Phase I application fee or an additional one. Confirm with the college before budgeting. Second, retakes require the respective examination fee, and the phase pages describe examination fees as nonrefundable, although the general fee page allows refunds only for extenuating circumstances accepted by the Board.
Applications are ordinarily due October 1 before the examination year, with intent to sit due by February 1. The currently dated checklist covers October 1, 2025 and February 1, 2026.
Remote Delivery and Exam-Day Logistics
For the published 2026 administrations, both phases were delivered remotely through ExamSoft. This dated notice takes precedence over generic phase-page references to a testing location, so verify the delivery mode for any future cycle.
- Candidates supply a compatible Windows or Mac laptop running Examplify, with administrator privileges.
- Encrypted examinations are downloaded in advance and unlocked with a proctor password.
- Examination mode blocks internet access, files and other applications.
- Advance practice examinations are available to rehearse the software and become familiar with question structure.
Use the practice examination early. Software surprises on exam day, from permission prompts to display issues, are avoidable and cost mental energy you need for the questions. Pair that rehearsal with realistic timed practice on our practice test site, so the eight-hour endurance demand does not first hit you on exam day.
What Is Not Published About Scoring
Candidates often ask for a numerical pass mark and a pass rate. Based on the public information verified here, neither is published. Passing points are recommended by the Examination Committee and ad hoc reviewers for Board approval, and a fixed numerical pass mark and a current pass rate were not verified. Be skeptical of any third-party source claiming exact figures. Our discussions of the passing score and the pass rate explain what can and cannot be said responsibly, and our difficulty guide frames the challenge qualitatively.
The practical implication: because you cannot target a known cut score, aim for broad competence across all headings rather than optimizing around a guessed threshold.
Careers and Maintenance After Certification
Board-certified clinical pharmacologists typically work where drug behavior and evaluation are central, including academic veterinary programs and research settings, and in roles tied to drug development and regulation. The breadth of Domain 25 (study design and analytics) and Domain 26 (regulatory pharmacology) points toward exactly these environments. Our resources on DACVCP jobs, the salary guide and the ROI analysis explore the career side without relying on invented figures.
On maintenance, the current Committees page confirms that a Maintenance of Certification committee administers recertification. Historical bylaws, approved June 2018, describe review of maintenance records every two years toward maintenance at ten years, but the complete legacy file was not retrieved, and its current applicability is unverified. No current renewal hours, fees or interval should be inferred from it. Confirm directly with the college.
Sequencing Your Preparation by Domain
Rather than a generic weekly template, sequence your work by how the domains build on each other. The logic below applies to Phase I preparation, and the principle carries into Phase II.
Quantitative foundations
- Domains 1-4: physiochemical properties, pharmacodynamics, drug movement, pharmacokinetics
- Why first: every later system and drug class assumes you can reason quantitatively
Variability and failure
- Domains 5-9: variability factors, routes, dosing forms, adverse events, therapeutic failure
- Why second: these apply the foundations to real-world messiness
Systems and classes
- Domains 10-22: organ systems, inflammation, anticancer, fluids, anti-infectives, botanicals, antiseptics
- Why third: the largest content volume, best learned once principles are solid
Phase II application
- Domains 23-26: therapeutics, TDM, experimental design and statistics, regulatory
- Practice written responses and data interpretation under timed conditions
Use spaced review to revisit Block 1 material throughout, since pharmacokinetic reasoning resurfaces everywhere. For a fuller plan, see our DACVCP study guide, and keep the DACVCP cheat sheet handy for quick review of high-yield facts.
Frequently Asked Questions
Yes. The complete credential requires both Phase I and Phase II, and both must be passed within the five-year eligibility period that begins with the first eligible examination year after Phase I approval.
Phase I consists of 200 multiple-choice questions in two 100-question sessions. Phase II has ten question groups combining written responses, multiple choice, fill-in-the-blank and extended matching, worth 200 points across two 100-point sessions. The 200 is a point total, not a question count.
Two peer-reviewed papers accepted or published by February 1 of the examination year. At least one must be original veterinary clinical pharmacology research, at least one must have you as first author, neither may have been used for another specialty board, and publication must not predate training by more than two years.
The published 2026 administrations were remote using ExamSoft, with candidates supplying a compatible laptop running Examplify. A 2027 schedule and delivery arrangement was not verified, so check the college's candidate information page for the current cycle.
Not in the sources verified here. Passing points are recommended by the Examination Committee and ad hoc reviewers for Board approval, and neither a fixed numerical pass mark nor a current pass rate was confirmed.